FI114468B - Farmaseuttisina aineina hyödyllisiä katekolidieetterijohdannaisia - Google Patents

Farmaseuttisina aineina hyödyllisiä katekolidieetterijohdannaisia Download PDF

Info

Publication number
FI114468B
FI114468B FI974442A FI974442A FI114468B FI 114468 B FI114468 B FI 114468B FI 974442 A FI974442 A FI 974442A FI 974442 A FI974442 A FI 974442A FI 114468 B FI114468 B FI 114468B
Authority
FI
Finland
Prior art keywords
group
alkyl
compound
formula
compound according
Prior art date
Application number
FI974442A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI974442A0 (fi
FI974442A (fi
Inventor
Allen J Duplantier
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI974442A0 publication Critical patent/FI974442A0/fi
Publication of FI974442A publication Critical patent/FI974442A/fi
Application granted granted Critical
Publication of FI114468B publication Critical patent/FI114468B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Dental Preparations (AREA)
FI974442A 1995-06-07 1997-12-05 Farmaseuttisina aineina hyödyllisiä katekolidieetterijohdannaisia FI114468B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1995/007208 WO1996040636A1 (en) 1995-06-07 1995-06-07 Catechol diethers derivatives useful as pharmaceutical agents
US9507208 1995-06-07

Publications (3)

Publication Number Publication Date
FI974442A0 FI974442A0 (fi) 1997-12-05
FI974442A FI974442A (fi) 1997-12-05
FI114468B true FI114468B (fi) 2004-10-29

Family

ID=22249266

Family Applications (1)

Application Number Title Priority Date Filing Date
FI974442A FI114468B (fi) 1995-06-07 1997-12-05 Farmaseuttisina aineina hyödyllisiä katekolidieetterijohdannaisia

Country Status (11)

Country Link
US (1) US6028086A (da)
EP (1) EP0869945B1 (da)
JP (1) JP3410104B2 (da)
AT (1) ATE237589T1 (da)
CA (1) CA2223245C (da)
DE (1) DE69530429T2 (da)
DK (1) DK0869945T3 (da)
ES (1) ES2193196T3 (da)
FI (1) FI114468B (da)
PT (1) PT869945E (da)
WO (1) WO1996040636A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9903919D0 (en) * 1999-02-19 1999-04-14 Darwin Discovery Ltd Aminophenols and their therapeutic use
SI1212089T1 (sl) 1999-08-21 2006-08-31 Altana Pharma Ag Sinergisticna kombinacija roflumilasta in salmeterola
CA2402384A1 (en) * 2000-03-16 2001-09-20 Inflazyme Pharmaceuticals Ltd. Benzylated pde4 inhibitors
WO2002102778A1 (fr) * 2001-06-15 2002-12-27 Yamanouchi Pharmaceutical Co., Ltd. Derive de phenylpyridinecarbonylpiperazine
CA2504820C (en) 2002-11-06 2011-08-23 Grelan Pharmaceutical Co., Ltd. Pyrazolonaphthyridine derivatives
US9463426B2 (en) * 2005-06-24 2016-10-11 Boston Scientific Scimed, Inc. Methods and systems for coating particles
CN101268073B (zh) 2005-09-15 2011-10-19 Aska制药株式会社 杂环化合物、制备方法及其用途
US8604031B2 (en) * 2006-05-18 2013-12-10 Mannkind Corporation Intracellular kinase inhibitors
EP2196465A1 (en) 2008-12-15 2010-06-16 Almirall, S.A. (3-oxo)pyridazin-4-ylurea derivatives as PDE4 inhibitors
EP2226323A1 (en) 2009-02-27 2010-09-08 Almirall, S.A. New tetrahydropyrazolo[3,4-c]isoquinolin-5-amine derivatives
EP2380890A1 (en) 2010-04-23 2011-10-26 Almirall, S.A. New 7,8-dihydro-1,6-naphthyridin-5(6h)-one-derivatives as PDE4 inhibitors
EP2394998A1 (en) 2010-05-31 2011-12-14 Almirall, S.A. 3-(5-Amino-6-oxo-1,6-dihydropyridazin-3-yl)-biphenyl derivatives as PDE4 inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE71647B1 (en) * 1991-01-28 1997-02-26 Rhone Poulenc Rorer Ltd Benzamide derivatives
GB9315595D0 (en) * 1993-07-28 1993-09-08 Res Inst Medicine Chem New compounds

Also Published As

Publication number Publication date
DE69530429T2 (de) 2003-10-30
ATE237589T1 (de) 2003-05-15
DE69530429D1 (de) 2003-05-22
CA2223245C (en) 2002-05-21
PT869945E (pt) 2003-09-30
JP2001527508A (ja) 2001-12-25
EP0869945B1 (en) 2003-04-16
FI974442A0 (fi) 1997-12-05
DK0869945T3 (da) 2003-07-14
JP3410104B2 (ja) 2003-05-26
ES2193196T3 (es) 2003-11-01
FI974442A (fi) 1997-12-05
MX9709869A (es) 1998-03-31
WO1996040636A1 (en) 1996-12-19
CA2223245A1 (en) 1996-12-19
US6028086A (en) 2000-02-22
EP0869945A1 (en) 1998-10-14

Similar Documents

Publication Publication Date Title
JP6843888B2 (ja) リジルオキシダーゼのハロアリルアミンインドールおよびアザインドール誘導体阻害剤およびその使用
FI114468B (fi) Farmaseuttisina aineina hyödyllisiä katekolidieetterijohdannaisia
JP3634861B2 (ja) 選択的ホスホジエステラーゼｉｖ阻害剤としての三置換フェニル誘導体
JP6782255B2 (ja) ヒストンデアセチラーゼ阻害薬及び組成物並びにそれらの使用の方法
US8563583B2 (en) Pyridone analogs useful as melanin concentrating hormone receptor-1 antagonists
RU2145597C1 (ru) Производные арилсульфониламиногидроксамовой кислоты, способ их получения, фармацевтическая композиция, способ ингибирования матричных металлопротеиназ и способ лечения
JP3131225B2 (ja) Ｎ−（アロイル）グリシンヒドロキサム酸誘導体および関連化合物
EP2307365B1 (en) Synthesis and use of heterocyclic antibacterial agents
KR20060036105A (ko) 피리딜 유도체 및 그의 치료제로서의 용도
JP2008019263A (ja) 置換２−アミノアセトアミドおよびその使用
JP3107827B2 (ja) トリサイクリック５，６−ジヒドロ−９Ｈ−ピラゾロ［３，４−ｃ］−１，２，４−トリアゾロ［４，３−ａ］ピリジン類
KR20150022789A (ko) 포스포디에스테라제 억제제로서 1-페닐-2-피리디닐 알킬 알코올의 유도체
HU214627B (hu) Eljárás 2,4- és 2,5-szubsztituált piridin-N-oxid-származékok, és hatóanyagként ezeket tartalmazó gyógyászati készítmények előállítására
JP2016517879A (ja) ニコチンアミドホスホリボシルトランスフェラーゼの阻害剤、組成物、生成物、およびその使用
JP2007507464A (ja) 新規のアミノピリジン誘導体
CN116462662A (zh) 芳香并环类Nav1.8抑制剂及其用途
CA2807886A1 (en) Substituted 1-oxo-dihydroisoquinoline-3-carboxamides as kcnq2/3 modulators
MXPA97009869A (en) Derivatives of useful catecol dieters, pharmaceutical compositions that contain them, yuso de los mis
JPH09132559A (ja) 化合物
JPH08217672A (ja) キサントン誘導体を含有する抗ヘリコバクター・ピロリ薬
KR20230131240A (ko) 가교된 헤테로사이클일-치환된 피리미딘 화합물, 이의제조 방법, 및 이의 의학적 용도
JP2004508312A (ja) 置換ヒドラジン誘導体
KR100386226B1 (ko) 2-페닐-3-아미노피리딘, 그의 치환된 페닐 유도체 및 그의염의 제조 방법
US4608381A (en) Antiinflammatory 2-(trifluoroethylsulfonyl)benzimidazoles
Durant et al. Histamine H3 receptor antagonists and therapeutic uses thereof

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 114468

Country of ref document: FI

MA Patent expired